GW Pharmaceuticals plc announced the appointment of Christopher John Tovey to the newly created position of Chief Operating Officer, effective October 1, 2012. Chris was most recently Vice President Global Marketing Operations at UCB Pharmaceuticals. Prior to joining UCB, Chris was Vice President Managing Director UK & Ireland at Nabi Biopharmaceuticals.

Before joining Nabi, Chris spent 18 years at GlaxoSmithKline, in senior commercial roles in both the European and UK organizations. These roles included Director Commercial Strategy Distribution Europe, Director European Vaccine Therapy Director Commercial Development UK, Director Vaccines Business Unit UK and Business Unit Manager Oncology UK.